PCRX
Pacira BioScienc (PCRX)
NASDAQ
$36.65+$0.19 (+0.52%)
Price as of Nov 12, 2026 8:21 AM EST
  • $1.5B
    Market Cap
  • 52.81%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry

Earnings Score

Score: 34
Valuation
PCRX
vs History
vs S&P 500
Profitability
-0
Growth
-0
Low Earnings Volatility
0

Momentum Score

Score: 53
Valuation
PCRX
vs History
vs S&P 500
3-Month Momentum
48.93%
12-Month Momentum
50.54%
3-Month Risk Adjusted Momentum
106.53%
12-Month Risk Adjusted Momentum
89.53%

True Yield

N/A
Valuation
PCRX
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
5.01%
Net Debt Paydown Yield
14.28%

Financial Health Score

Score: 81
Valuation
PCRX
vs History
vs S&P 500
Ohlson's O-Score
7